Proton-pump inhibitor recalled

One lot of pantoprazole sodium for injection (40 mg per vial) was recalled from hospitals nationwide, the FDA announced on Dec. 20, 2017.

The proton-pump inhibitor, given by IV infusion, is indicated for the short-term treatment of gastroesophageal reflux disease associated with a history of erosive esophagitis and pathological hypersecretion, including Zollinger-Ellison syndrome.

Manufacturer AuroMedics Pharma initiated the recall after a report that one vial from the 10-vial batch contained a piece of glass. Recalled products were shipped in August 2017.